EMEA-002213-PIP01-17
Key facts
| Active substance |
Sirolimus
|
| Therapeutic area |
Other
|
| Decision number |
P/0395/2017
|
| PIP number |
EMEA-002213-PIP01-17
|
| Pharmaceutical form(s) |
Implant
|
| Condition(s) / indication(s) |
Prevention of arteriovenous access dysfunction
|
| Route(s) of administration |
Implantation
|
| Contact for public enquiries |
Vascular Therapies, Inc.
Tel. +1 2012668310
E-mail: david@vasculartx.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|